186 related articles for article (PubMed ID: 26369679)
1. New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia.
Di Francesco L; López Contreras LA; Sacco A; Patrignani P
Curr Pharm Des; 2015; 21(35):5116-26. PubMed ID: 26369679
[TBL] [Abstract][Full Text] [Related]
2. Mode of action of aspirin as a chemopreventive agent.
Dovizio M; Bruno A; Tacconelli S; Patrignani P
Recent Results Cancer Res; 2013; 191():39-65. PubMed ID: 22893199
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract.
Bruno A; Dovizio M; Tacconelli S; Patrignani P
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):e1-e13. PubMed ID: 23199511
[TBL] [Abstract][Full Text] [Related]
4. Role of platelets in inflammation and cancer: novel therapeutic strategies.
Dovizio M; Alberti S; Guillem-Llobat P; Patrignani P
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):118-27. PubMed ID: 24118902
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
Schrör K
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
[TBL] [Abstract][Full Text] [Related]
6. Curbing tumorigenesis and malignant progression through the pharmacological control of the wound healing process.
Dovizio M; Sacco A; Patrignani P
Vascul Pharmacol; 2017 Feb; 89():1-11. PubMed ID: 28089842
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis.
Rohwer N; Kühl AA; Ostermann AI; Hartung NM; Schebb NH; Zopf D; McDonald FM; Weylandt KH
Cancer Med; 2020 Apr; 9(7):2535-2550. PubMed ID: 31994315
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and Cancer.
Patrignani P; Patrono C
J Am Coll Cardiol; 2016 Aug; 68(9):967-76. PubMed ID: 27561771
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
Maenthaisong R; Tacconelli S; Sritara P; Del Boccio P; Di Francesco L; Sacchetta P; Archararit N; Aryurachai K; Patrignani P; Suthisisang C
Int J Immunopathol Pharmacol; 2013; 26(2):403-17. PubMed ID: 23755755
[TBL] [Abstract][Full Text] [Related]
10. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
Guillem-Llobat P; Dovizio M; Bruno A; Ricciotti E; Cufino V; Sacco A; Grande R; Alberti S; Arena V; Cirillo M; Patrono C; FitzGerald GA; Steinhilber D; Sgambato A; Patrignani P
Oncotarget; 2016 May; 7(22):32462-77. PubMed ID: 27074574
[TBL] [Abstract][Full Text] [Related]
11. Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.
Ornelas A; Zacharias-Millward N; Menter DG; Davis JS; Lichtenberger L; Hawke D; Hawk E; Vilar E; Bhattacharya P; Millward S
Cancer Metastasis Rev; 2017 Jun; 36(2):289-303. PubMed ID: 28762014
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
Schrör K
Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
[TBL] [Abstract][Full Text] [Related]
14. Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression.
Servais L; Wéra O; Dibato Epoh J; Delierneux C; Bouznad N; Rahmouni S; Mazzucchelli G; Baiwir D; Delvenne P; Lancellotti P; Oury C
J Thromb Haemost; 2018 Apr; 16(4):762-777. PubMed ID: 29369476
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
16. Platelets, cyclooxygenases, and colon cancer.
Guillem-Llobat P; Dovizio M; Alberti S; Bruno A; Patrignani P
Semin Oncol; 2014 Jun; 41(3):385-96. PubMed ID: 25023354
[TBL] [Abstract][Full Text] [Related]
17. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
Dachineni R; Kumar DR; Callegari E; Kesharwani SS; Sankaranarayanan R; Seefeldt T; Tummala H; Bhat GJ
Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation in patients with colorectal cancer.
Sciulli MG; Filabozzi P; Tacconelli S; Padovano R; Ricciotti E; Capone ML; Grana M; Carnevale V; Patrignani P
Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):79-83. PubMed ID: 15626589
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal Cancer.
Patrignani P; Sacco A; Sostres C; Bruno A; Dovizio M; Piazuelo E; Di Francesco L; Contursi A; Zucchelli M; Schiavone S; Tacconelli S; Patrono C; Lanas A
Clin Pharmacol Ther; 2017 Jul; 102(1):52-61. PubMed ID: 28139830
[TBL] [Abstract][Full Text] [Related]
20. [Aspirin and colorectal cancer].
Grancher A; Michel P; Di Fiore F; Sefrioui D
Bull Cancer; 2018 Feb; 105(2):171-180. PubMed ID: 29153543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
